GenCure uses the power of human cells and tissues to heal.
GenCure applies advances in regenerative medicine to help heal patients suffering from trauma, disease or the aging process. Using processed tissue and cell-based therapies, GenCure works to connect needs with solutions.
We specialize in the collection, development and processing of a diverse range of components for human therapeutic and research applications. As a bio-medical partner, GenCure provides human cell and tissue procurement services as well as the facilities and expertise to ensure cGMP-compliant processing of materials in support of research and clinical programs.
Our services include providing cord blood and related tissues, and peripheral blood stem cell collection services to support the new generation of immune-based therapies. In addition, bone marrow donor services are provided for patients in need of lifesaving bone marrow transplant, and allogeneic tissue harvesting and processing services are available for tissue repair, replacement and reconstruction procedures.
GenCure is both a direct supplier to healthcare providers and a partner with commercial and nonprofit organizations providing regenerative medicine treatments to patients. The collections, processing and laboratory facilities include ISO-classified clean rooms, processing facilities, and testing laboratories that meet international regulatory standards. GenCure is dedicated to fulfilling regenerative medicine’s potential to heal human conditions previously incurable.
GenCure’s services are accredited by:
- American Association of Blood Banks (AABB)
- American Association of Tissue Banks (AATB)
- International Organization of Standardization (ISO)
- Clinical Laboratory Improvements Amendments (CLIA)
- Food and Drug Administration (FDA), and state licensing agencies where applicable.